Other Income & Expense
Other Non-Cash Items
Pfizer Other Non-Cash Items decreased by 20.5% to $93.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 332.5%, from -$40.00M to $93.00M. Over 2 years (FY 2023 to FY 2025), Other Non-Cash Items shows a downward trend with a -63.3% CAGR.
Analysis
StatementIncome Statement
SectionOther Income & Expense
First reportedQ1 2013
Last reportedQ1 2026May 5, 2026
Metric ID:
tmo_other_noncash_income_expenseHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.01B | $543.00M | -$815.00M | -$455.00M | -$211.00M | -$99.00M | $416.00M | $427.00M | $2.75B | $151.00M | -$411.00M | $715.00M | $1.81B | -$40.00M | $101.00M | $292.00M | $117.00M | $93.00M |
| QoQ Change | — | -46.4% | -250.1% | +44.2% | +53.6% | +53.1% | +520.2% | +2.6% | +543.6% | -94.5% | -372.2% | +274.0% | +152.4% | -102.2% | +352.5% | +189.1% | -59.9% | -20.5% |
| YoY Change | — | — | — | -144.9% | -138.9% | +87.9% | +191.4% | +302.4% | — | +252.5% | -198.8% | +67.4% | -34.3% | -126.5% | +124.6% | -59.2% | -93.5% | +332.5% |
Range-$815.00M – $2.75B
CAGR-43.0%
Avg YoY Growth+40.2%
Median YoY Growth+16.6%
Current Streak2 quarters decline
Other Non-Cash Items at Other Companies
Frequently Asked Questions
- What is Pfizer's other non-cash items?
- Pfizer (PFE) reported other non-cash items of $93.00M in Q1 2026.
- How has Pfizer's other non-cash items changed year-over-year?
- Pfizer's other non-cash items increased by 332.5% year-over-year, from -$40.00M to $93.00M.
- What is the long-term trend for Pfizer's other non-cash items?
- Over 2 years (2023 to 2025), Pfizer's other non-cash items has grown at a -63.3% compound annual growth rate (CAGR), from $3.49B to $470.00M.